Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003.

MLA

Teshale, Eyasu H., et al. “Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine on Pneumonia in HIV-Infected Adults in the United States, 1998--2003.” Vaccine, vol. 26, no. 46, Oct. 2008, pp. 5830–34. EBSCOhost, https://doi.org/10.1016/j.vaccine.2008.08.032.

APA

Teshale, E. H., Hanson, D., Flannery, B., Phares, C., Wolfe, M., Schuchat, A., & Sullivan, P. (2008). Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998--2003. Vaccine, 26(46), 5830–5834. https://doi.org/10.1016/j.vaccine.2008.08.032

Chicago

Teshale, Eyasu H, Debra Hanson, Brendan Flannery, Christina Phares, Mitchell Wolfe, Anne Schuchat, and Patrick Sullivan. 2008. “Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine on Pneumonia in HIV-Infected Adults in the United States, 1998--2003.” Vaccine 26 (46): 5830–34. doi:10.1016/j.vaccine.2008.08.032.